Dr. Anna Spreafico, MD PhD
Claim this profilePrincess Margaret Cancer Centre
Studies Cancer
Studies Squamous Cell Carcinoma
11 reported clinical trials
23 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
MSI-H positive
2Squamous Cell Carcinoma
Stage III
Stage IV
p16 positive
Affiliated Hospitals
Clinical Trials Anna Spreafico, MD PhD is currently running
SGN-PDL1V
for Cancer
This trial is testing a new drug, SGN-PDL1V, alone and with pembrolizumab, in patients with advanced solid tumors. The goal is to see if these treatments are safe and effective. SGN-PDL1V targets cancer cells directly, while pembrolizumab helps the immune system fight the cancer.
Recruiting1 award Phase 1
TAK-280
for Advanced Cancer
The main aim of this study is to find out the safety, tolerability, and effect of TAK- 280 in participants with unresectable, locally advanced or metastatic cancer who have experienced treatment failure or are intolerant to standard therapies. Participants will be treated with TAK-280 for up to 14 treatment cycles. Each treatment cycle will be 28 days. After the last dose of study drug, participants will be followed up for survival every 12 weeks for a total of 48 weeks.
Recruiting1 award Phase 1 & 2
More about Anna Spreafico, MD PhD
Clinical Trial Related6 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Anna Spreafico, MD PhD has experience with
- Nivolumab
- Anti-androgen
- MEK Or PI3K Inhibitor
- C-KIT Inhibitor
- Selinexor
- EGFR Or HER2 Inhibitor
Breakdown of trials Anna Spreafico, MD PhD has run
Squamous Cell Carcinoma
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anna Spreafico, MD PhD specialize in?
Anna Spreafico, MD PhD focuses on Cancer and Squamous Cell Carcinoma. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Anna Spreafico, MD PhD currently recruiting for clinical trials?
Yes, Anna Spreafico, MD PhD is currently recruiting for 4 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that Anna Spreafico, MD PhD has studied deeply?
Yes, Anna Spreafico, MD PhD has studied treatments such as Nivolumab, Anti-androgen, MEK or PI3K Inhibitor.
What is the best way to schedule an appointment with Anna Spreafico, MD PhD?
Apply for one of the trials that Anna Spreafico, MD PhD is conducting.
What is the office address of Anna Spreafico, MD PhD?
The office of Anna Spreafico, MD PhD is located at: Princess Margaret Cancer Centre, Toronto, Ontario M5G 2M9 Canada. This is the address for their practice at the Princess Margaret Cancer Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.